Showing results (1-10 of 27) with videos related to
Sort By:
Pageof 3
Cancer Genetics and Cytogenetics|May 14, 2008
Contemplations on preclinical validation of fluorescence in situ hybridization probe assay for paraffin-embedded tissues in hematologic disordersKavita S Reddy, Joseph TripodiCancer Management and Research|December 29, 2010
Frequency of heterozygous TET2 deletions in myeloproliferative neoplasmsJoseph Tripodi, Ronald Hoffman, Vesna Najfeld, et al.Molecular Cytogenetics|October 22, 2025
Long-read sequencing unmasks a cryptic three-way translocation resulting in an ETV6::PDGFRB fusionJoseph Tripodi, Douglas Tremblay, Daiva Ahire, et al.Case Reports in Hematology|April 15, 2026
Acute Myeloid Leukemia, Myelodysplasia-Related (AML-MR), With del(5q) and Double Minutes Containing Chromosomal Segment 11q24 Leading to Amplification and Expression of FLI1Satomi Hiya, Joseph Tripodi, John Mascarenhas, et al.Springerplus|August 28, 2015
Analysis of ALK gene in 133 patients with breast cancer revealed polysomy of chromosome 2 and no ALK amplificationMatthew G Hanna, Vesna Najfeld, Hanna Y Irie, et al.Cancer Genetics|April 21, 2011
Development of t(8;21) and RUNX1-RUNX1T1 in the Philadelphia-positive clone of a patient with chronic myelogenous leukemia: additional evidence for multiple steps involved in disease progressionVesna Najfeld, Nathaniel Wisch, John Mascarenhas, et al.International Journal of Molecular Sciences|April 13, 2024
Conventional Cytogenetic Analysis and Array CGH + SNP Identify Essential Thrombocythemia and Prefibrotic Primary Myelofibrosis Patients Who Are at Risk for Disease ProgressionJoseph Tripodi, Ronald Hoffman, Douglas Tremblay, et al.Journal of Virology|May 6, 2011
Multiploid inheritance of HIV-1 during cell-to-cell infectionArmando Del Portillo, Joseph Tripodi, Vesna Najfeld, et al.Molecular Cytogenetics|November 28, 2023
Chromothripsis in lipoblastoma: second reported case with complex PLAG1 rearrangementJoel Lanceta, Joseph Tripodi, Lynne Karp, et al.Blood|September 23, 2010
Sequential treatment of CD34+ cells from patients with primary myelofibrosis with chromatin-modifying agents eliminate JAK2V617F-positive NOD/SCID marrow repopulating cellsXiaoli Wang, Wei Zhang, Joseph Tripodi, et al.Pageof 3